Drug
Fazisiran
Fazisiran: highest development phase Phase 2, developed by Arrowhead Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Arrowhead Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fazisiran Injection NCT03945292 | Phase 2 | Alpha 1-Antitrypsin Deficiency |
Latest
No recent events.
Follow Fazisiran on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.